190 related articles for article (PubMed ID: 35135554)
1. Relationship of cytochrome P450 gene polymorphisms with blood concentrations of hydroxychloroquine and its metabolites and adverse drug reactions.
Gao B; Tan T; Cao X; Pan M; Yang C; Wang J; Shuai Z; Xia Q
BMC Med Genomics; 2022 Feb; 15(1):23. PubMed ID: 35135554
[TBL] [Abstract][Full Text] [Related]
2. Genotype-guided new approach for dose optimisation of hydroxychloroquine administration in Chinese patients with SLE.
Xie H; Wen X; Wang Y; Huang X; Shu Q; Wang D; Geng L; Jin Z; Shen W; Ge W; Zhu Y; Sun L
Lupus Sci Med; 2023 Nov; 10(2):. PubMed ID: 37993281
[TBL] [Abstract][Full Text] [Related]
3. Association of Polymorphisms of Cytochrome P450 2D6 With Blood Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus.
Lee JY; Vinayagamoorthy N; Han K; Kwok SK; Ju JH; Park KS; Jung SH; Park SW; Chung YJ; Park SH
Arthritis Rheumatol; 2016 Jan; 68(1):184-90. PubMed ID: 26316040
[TBL] [Abstract][Full Text] [Related]
4. The presumable effects of hydroxychloroquine and its metabolites in the treatment of systemic lupus erythematosus.
Pan M; Jin R; Dai Y; Gao B; Liu Y; Peng X; Qiao J; Shuai Z
Int Immunopharmacol; 2024 Jan; 126():111269. PubMed ID: 38006753
[TBL] [Abstract][Full Text] [Related]
5. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
Rainsford KD; Parke AL; Clifford-Rashotte M; Kean WF
Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
[TBL] [Abstract][Full Text] [Related]
6. Whole blood hydroxychloroquine: Does genetic polymorphism of cytochrome P450 enzymes have a role?
Jatta N; Stanslas J; Yong ACH; Ho WC; Wan Ahmad Kammal WSL; Chua EW; How KN
Clin Exp Med; 2023 Dec; 23(8):4141-4152. PubMed ID: 37480404
[TBL] [Abstract][Full Text] [Related]
7. Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus.
Penn SK; Kao AH; Schott LL; Elliott JR; Toledo FG; Kuller L; Manzi S; Wasko MC
J Rheumatol; 2010 Jun; 37(6):1136-42. PubMed ID: 20436082
[TBL] [Abstract][Full Text] [Related]
8. Continuation Rate, Safety and Efficacy of Hydroxychloroquine Treatment in a Retrospective Cohort of Systemic Lupus Erythematosus in a Japanese Municipal Hospital.
Hosokawa Y; Oiwa H
Intern Med; 2020 Oct; 59(20):2485-2490. PubMed ID: 32641656
[TBL] [Abstract][Full Text] [Related]
9. Hydroxychloroquine Serum Concentrations and Flares of Systemic Lupus Erythematosus: A Longitudinal Cohort Analysis.
Mok CC; Penn HJ; Chan KL; Tse SM; Langman LJ; Jannetto PJ
Arthritis Care Res (Hoboken); 2016 Sep; 68(9):1295-302. PubMed ID: 26749299
[TBL] [Abstract][Full Text] [Related]
10. Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus.
Jallouli M; Galicier L; Zahr N; Aumaître O; Francès C; Le Guern V; Lioté F; Smail A; Limal N; Perard L; Desmurs-Clavel H; Le Thi Huong D; Asli B; Kahn JE; Pourrat J; Sailler L; Ackermann F; Papo T; Sacré K; Fain O; Stirnemann J; Cacoub P; Leroux G; Cohen-Bittan J; Sellam J; Mariette X; Blanchet B; Hulot JS; Amoura Z; Piette JC; Costedoat-Chalumeau N;
Arthritis Rheumatol; 2015 May; 67(8):2176-84. PubMed ID: 25989906
[TBL] [Abstract][Full Text] [Related]
11. Skin and ophthalmic complications of chloroquine and hydroxychloroquine in patients with rheumatoid arthritis and systemic lupus erythematous.
Zamani B; Hasan-Abad AM; Rafizadeh SM; Akbari H; Motedayyen H
J Immunoassay Immunochem; 2024 May; 45(3):178-188. PubMed ID: 38722204
[TBL] [Abstract][Full Text] [Related]
12. Factors Related to Blood Hydroxychloroquine Concentration in Patients With Systemic Lupus Erythematosus.
Yeon Lee J; Lee J; Ki Kwok S; Hyeon Ju J; Su Park K; Park SH
Arthritis Care Res (Hoboken); 2017 Apr; 69(4):536-542. PubMed ID: 27390146
[TBL] [Abstract][Full Text] [Related]
13. Association of Higher Hydroxychloroquine Blood Levels With Reduced Thrombosis Risk in Systemic Lupus Erythematosus.
Petri M; Konig MF; Li J; Goldman DW
Arthritis Rheumatol; 2021 Jun; 73(6):997-1004. PubMed ID: 33403833
[TBL] [Abstract][Full Text] [Related]
14. Effect of hydroxychloroquine blood concentration on the efficacy and ocular toxicity of systemic lupus erythematosus.
Liu PC; Luo SL; Lv MN; Wang Y; Li JB; Yu SJ; Wu R
Sci Rep; 2024 Apr; 14(1):7674. PubMed ID: 38561370
[TBL] [Abstract][Full Text] [Related]
15. The influence of obesity on hydroxychloroquine blood levels in lupus nephritis patients.
Pedrosa T; Kupa LVK; Pasoto SG; Aikawa NE; Borba EF; Duarte NJ; Leon EP; Silva CA; Bonfá E
Lupus; 2021 Apr; 30(4):554-559. PubMed ID: 33402039
[TBL] [Abstract][Full Text] [Related]
16. Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study.
Jallouli M; Francès C; Piette JC; Huong du LT; Moguelet P; Factor C; Zahr N; Miyara M; Saadoun D; Mathian A; Haroche J; De Gennes C; Leroux G; Chapelon C; Wechsler B; Cacoub P; Amoura Z; Costedoat-Chalumeau N;
JAMA Dermatol; 2013 Aug; 149(8):935-40. PubMed ID: 23824340
[TBL] [Abstract][Full Text] [Related]
17. Simple dose-escalation regimen for hydroxychloroquine-induced hypersensitivity reaction in patients with systemic lupus erythematosus enabled treatment resumption.
Takamasu E; Yokogawa N; Shimada K; Sugii S
Lupus; 2019 Oct; 28(12):1473-1476. PubMed ID: 31575325
[TBL] [Abstract][Full Text] [Related]
18. Association between hydroxychloroquine levels and disease activity in a predominantly Hispanic systemic lupus erythematosus cohort.
Geraldino-Pardilla L; Perel-Winkler A; Miceli J; Neville K; Danias G; Nguyen S; Dervieux T; Kapoor T; Giles J; Askanase A
Lupus; 2019 Jun; 28(7):862-867. PubMed ID: 31122136
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of a Fast Ultra-High Performance Liquid Chromatography-Fluorescent Method for the Quantification of Hydroxychloroquine and Its Metabolites in Patients With Lupus.
Noé G; Amoura Z; Combarel D; Lori L; Tissot N; Seycha A; Funck-Brentano C; Zahr N
Ther Drug Monit; 2019 Aug; 41(4):476-482. PubMed ID: 30807538
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Hydroxychloroquine Therapy for Systemic Lupus Erythematosus Patients Depend on Administration Dose.
Wakiya R; Kameda T; Nakashima S; Shimada H; Fahmy Mansour MM; Kato M; Miyagi T; Kadowaki N; Dobashi H
Intern Med; 2020 Sep; 59(17):2105-2112. PubMed ID: 32522920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
